Chief Operating Officer and President of Global Commercial Products, Orexigen Therapeutics, Inc.
Thomas Cannell joined Orexigen in 2015 as Chief Commercial Officer. In 2016, he has promoted to Chief Operating Officer and President of Global Commercial Products. Prior to Orexigen, Tom spent 27 years at Merck where he held senior leadership positions in global commercialization, consumer marketing, and sales operations and management. At Merck, Tom’s assignments included President of Merck Canada (2012 – 2014) and Head of Marketing and Strategy for MSD Japan (2010-2012). Earlier he served in general manager roles for a U.S. sales division, as leader of a Merck business unit, managing a multi-billion dollar product portfolio and thousands of employees, and as General Manager, New Commercial Model, U.S., where he designed and successfully piloted an innovative, customer-centric commercial model for Merck’s U.S. business. Tom holds a Bachelor of Science degree in Veterinary Science and a Doctor of Veterinary Medicine degree from Washington State University. He has also served in the U.S. Army Reserves (currently inactive) since 1987.